Be the first to like.

Share

Commenting on the study for Medscape Medical News, Brendan Saloner, PhD, assistant professor of health policy and management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, who was not involved with the research, said that it “has long been a hope that because buprenorphine can be prescribed by office-based clinicians, it would help to ‘mainstream’¬†addiction¬†treatment and make it a broadly accessible service that is reimbursed by insurance, like all other chronic diseases.”

However, “the reality is different [and] buprenorphine patients remain disproportionately white and, while whites are more likely to have opioid addiction, the difference in prevalence alone is unlikely to explain this gap,” he continued.

Another “big difference” is self-payment.

“Many patients opt to self-pay because their insurance is not sufficiently comprehensive or they do not want to disclose that they have a substance use disorder,” he pointed out.

…continue reading ‘Dramatic Racial, Ethnic Disparities in Access to Buprenorphine’

Image: By Tmeers91 – Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=46998018

Be the first to like.

Share
Medscape

Tags: , , , , , , , , ,

Leave a Reply